Hyperferritinemia as a Clue to Neuroendocrine Carcinoma

By afschroeder • September 16, 2025

Chao ES, Yoshikawa G, Qing X, Huang C. Hyperferritinemia as a Clue to Neuroendocrine Carcinoma. Cureus. 2025 Aug 13;17(8):e90020. doi: 10.7759/cureus.90020. PMID: 40951183; PMCID: PMC12431798.

Tags: anemia workup, Fellow, General Internal Medicine, Harbor UCLA, Hematology/Oncology, hyperferritinemia, neuroendocrine carcinoma of prostate, neuroendocrine differentiation, poorly differentiated metastatic carcinoma, Publications, Resident

Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of Physicians

Qaseem A, Fitterman N, Tierney S, Powell RE, Campos K, Choi EI, Crandall CJ, Cross JT Jr, Humphrey LL, Obley AJ, Wilt TJ, Andrews RA;[...]

Invited Commentary: “Patient-reported health-related social needs obtained at the bedside and outcomes after elective major surgery”

Justo M, Mahrokhi S, Kropp R, Benharash P. Invited Commentary: "Patient-reported health-related social needs obtained at the bedside and outcomes after elective major surgery". Surgery.[...]

Differences Among Veterans With Chronic Overlapping Pain Conditions and Other Chronic Pain: Baseline Results From the LAMP Pain Management Trial

Adamowicz JL, Grant A, Calvert C, Elchert D, Hadlandsmyth K, Driscoll MA, Taylor SL, Allen K, Taylor BC, Burgess DJ. Differences Among Veterans With Chronic[...]